Minhua Zheng

ruijin hospital

H指数:31

被引数:3,418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1

结直肠癌中与CAF相关的预后和治疗反应标志物的开发与验证：HSPB1的新见解

npj Precision Oncology

IF8

2025-12-170

OAAI

ST6GAL1-Mediated Sialylation Stabilizes PD-L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer

ST6GAL1介导的唾液酸化稳定PD-L1并驱动结直肠癌免疫抑制性肿瘤微环境

Advanced Science

IF14.1

2025-08-220

OAAI

Short-term outcomes of transanal endoscopic intersphincteric resection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A single-center retrospective cohort study

新辅助放化疗后经肛门内镜括约肌间切除术治疗局部进展期直肠癌的短期疗效: 一项单中心回顾性队列研究

EJSO

IF2.9

2025-04-010

PRE

YTHDC1 is a therapeutic target for B-cell acute lymphoblastic leukemia by attenuating DNA damage response through the KMT2C-H3K4me1/me3 epigenetic axis

LEUKEMIA

IF13.4

2024-11-050

PRE

Genes controlling grain chalkiness in rice

控制水稻籽粒垩白的基因

CROP JOURNAL

IF5.6

2024-08-014

OAAI

Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancer

全面的多组学分析和实验验证揭示PFDN5是一种新型的胃癌预后和治疗生物标志物

GENOMICS

IF3

2024-03-012

OAAI

Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer

多胺代谢模式表征结直肠癌的肿瘤微环境，预后和对免疫疗法的反应

CANCER CELL INTERNATIONAL

IF6

2023-05-186

OAAI

FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β-catenin nuclear localization

ONCOLOGY REPORTS

IF3.9

2023-05-158

OAAI

Pathological and perioperative outcomes of extracorporeal versus intracorporeal anastomosis in laparoscopic transverse colon cancer resection: retrospective multicentre study

BJS OPEN

IF4.5

2023-05-106

OAAI

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

肿瘤浸润b细胞在人类癌症中的作用和机制: 免疫治疗的新力量

BIOMARKER RESEARCH

IF11.5

2023-03-0932

OAAI

Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with Crohn's disease

FRONTIERS IN NUTRITION

IF5.1

2023-01-066

OAAI

LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-12-0810

PRE

Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-162

OAAI

ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy in metastatic colorectal cancer

ACACB是预测转移性结直肠癌对西妥昔单抗治疗反应的新型代谢相关生物标志物

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2022-09-134

OAAI

Academic surgery amid the COVID-19 pandemic: A perspective of the present and future challenges

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2022-08-012

OAAI

Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

MTOR的基因组签名可能是人类结直肠癌的免疫原性标记

BMC CANCER

IF3.4

2022-07-263

OAAI

Platelet infiltration predicts survival in postsurgical colorectal cancer patients

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2021-10-1919

Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology

非编码RNA的表观遗传调控: 癌症生物学的新维度

MOLECULAR CANCER

IF33.9

2020-03-2473

OAAI

METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST

METTL14通过下调致癌长链非编码RNA XIST抑制结直肠癌的增殖和转移

MOLECULAR CANCER

IF33.9

2020-02-28386

OAAI

Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer

BIOSCIENCE REPORTS

IF4.7

2020-02-1423

OAAI

Minhua Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向